Article and Video CATEGORIES

Cancer Journey

Search By

Panel Q&A Session on Acquired Resistance with Drs. Reckamp & Owonikoko
Author
GRACE Videos and Articles

AR_2015_QA_Reckamp_Owonikoko_Acquired_Resistance

 

Dr. West moderates a question & answer session with Drs. Karen Reckamp and Taofeek Owonikoko on issues of acquired resistance to targeted therapies for patients with advanced NSCLC that harbors a driver mutation.

[powerpress]

[ratingwidget post_id=0]

Please feel free to offer comments and raise questions in our Discussion Forums.

Next Previous link

Previous PostNext Post

Related Content

Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora